These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6775004)

  • 41. A protease stable in organic solvents from solvent tolerant strain of Pseudomonas aeruginosa.
    Gupta A; Khare SK
    Bioresour Technol; 2006 Oct; 97(15):1788-93. PubMed ID: 16242320
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of protease production of various bacteria by ammonium salts: its effect on toxin production and virulence.
    Liu PV; Hsieh HC
    J Bacteriol; 1969 Aug; 99(2):406-13. PubMed ID: 4309097
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biological and immunochemical properties of culture filtrates of virulent and avirulent strains of Pseudomonas aeruginosa.
    Carney SA; Jones RJ
    Br J Exp Pathol; 1968 Oct; 49(5):395-410. PubMed ID: 4973303
    [No Abstract]   [Full Text] [Related]  

  • 44. Antibodies to proteases and exotoxin A of Pseudomonas aeruginosa in patients with cystic fibrosis: Demonstration by radioimmunoassay.
    Klinger JD; Straus DC; Hilton CB; Bass JA
    J Infect Dis; 1978 Jul; 138(1):49-8. PubMed ID: 98596
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ethanol effects on Pseudomonas aeruginosa lectin, protease, hemolysin, pyocyanin, autoinducer, and phosphatase levels depending on medium composition and choline presence.
    Katri N; Gilboa-Garber N
    Curr Microbiol; 2007 Apr; 54(4):296-301. PubMed ID: 17308940
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Antibacterial activity of 9 antibiotics in relation to serotype and enzyme production of Pseudomonas aeruginosa].
    Tsukiyama F; Katoh M; Iida T; Nakamura K; Watanabe T; Ikeda M; Muroki K; Fujiue Y; Kuwabara M
    Jpn J Antibiot; 1982 Dec; 35(12):2805-11. PubMed ID: 6820667
    [No Abstract]   [Full Text] [Related]  

  • 47. Pseudomonas aeruginosa proteolytically alters the interleukin 22-dependent lung mucosal defense.
    Guillon A; Brea D; Morello E; Tang A; Jouan Y; Ramphal R; Korkmaz B; Perez-Cruz M; Trottein F; O'Callaghan RJ; Gosset P; Si-Tahar M
    Virulence; 2017 Aug; 8(6):810-820. PubMed ID: 27792459
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Selective inhibition of the accumulation of extracellular proteases of Pseudomonas aeruginosa by gentamicin and tobramycin.
    Warren RL; Baker NR; Johnson J; Stapleton MJ
    Antimicrob Agents Chemother; 1985 Apr; 27(4):468-72. PubMed ID: 3923920
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Purification and characterization of exocellular proteases produced by a clinical isolate and a laboratory strain of Pseudomonas aeruginosa.
    Jensen SE; Phillippe L; Teng Tseng J; Stemke GW; Campbell JN
    Can J Microbiol; 1980 Jan; 26(1):77-86. PubMed ID: 6250687
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A protease with staphylolytic activity from Pseudomonas aeruginosa PAKS I.
    Carnicero A; Falcón MA; Mansito TB; Roldán JM
    FEMS Microbiol Lett; 1990 Jul; 58(2):171-5. PubMed ID: 2121586
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Effects of an antiserum prepared against purified protease of pseudomonas aeruginosa (authors transl)].
    Sezen IY; Scharmann W; Blobel H
    Zentralbl Bakteriol Orig A; 1975; 231(1-3):126-32. PubMed ID: 808047
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Secreted LasA of Pseudomonas aeruginosa is a staphylolytic protease.
    Kessler E; Safrin M; Olson JC; Ohman DE
    J Biol Chem; 1993 Apr; 268(10):7503-8. PubMed ID: 8463280
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Corneal virulence of Pseudomonas aeruginosa elastase B and alkaline protease produced by Pseudomonas putida.
    Thibodeaux BA; Caballero AR; Marquart ME; Tommassen J; O'Callaghan RJ
    Curr Eye Res; 2007 Apr; 32(4):373-86. PubMed ID: 17453960
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The roles of various fractions of Pseudomonas aeruginosa in its pathogenesis. 3. Identity of the lethal toxins produced in vitro and in vivo.
    Liu PV
    J Infect Dis; 1966 Oct; 116(4):481-9. PubMed ID: 4959184
    [No Abstract]   [Full Text] [Related]  

  • 55. Effect of substrate on the regulation of exoprotease production by Pseudomonas aeruginosa ATCC 10145.
    Whooley MA; O'Callaghan JA; McLoughlin AJ
    J Gen Microbiol; 1983 Apr; 129(4):981-8. PubMed ID: 6411860
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Production of extracellular substances by different virulent strains of Pseudomonas aeruginosa.
    Muszyński Z; Kedzia WB
    J Hyg Epidemiol Microbiol Immunol; 1974; 18(3):313-5. PubMed ID: 4214475
    [No Abstract]   [Full Text] [Related]  

  • 57. Pseudomonas deficient in protease IV has significantly reduced corneal virulence.
    Engel LS; Hobden JA; Moreau JM; Callegan MC; Hill JM; O'Callaghan RJ
    Invest Ophthalmol Vis Sci; 1997 Jul; 38(8):1535-42. PubMed ID: 9224281
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Isolation and characterization of alkaline protease-deficient mutants of Pseudomonas aeruginosa in vitro and in a mouse eye model.
    Howe TR; Iglewski BH
    Infect Immun; 1984 Mar; 43(3):1058-63. PubMed ID: 6421735
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Purification and properties of a protease with elastase activity from Pseudomonas aeruginosa.
    Wretlind B; Wadström T
    J Gen Microbiol; 1977 Dec; 103(2):319-27. PubMed ID: 413876
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Production of proteinase on noncarbohydrate carbon sources by Pseudomonas aeruginosa.
    Morihara K
    Appl Microbiol; 1965 Sep; 13(5):793-7. PubMed ID: 5867657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.